您的位置: 首页 > 农业专利 > 详情页

substituted benzimidazole derivative as a modulator of tnf activity
专利权人:
UCB BIOPHARMA SPRL
发明人:
JAG PAUL HEER
申请号:
BR112019008766
公开号:
BR112019008766A2
申请日:
2017.12.08
申请国别(地区):
BR
年份:
2019
代理人:
摘要:
The present patent application relates to 2- (5- {1- [2- (difluoromethoxy) -6-fluorobenzyl] -2-methyl-1h-benzimidazol-6-yl} pyrimidin-2-yl) propan-2 -ol, or a pharmaceutically acceptable salt thereof, being potent modulators of human activity, are therefore of benefit in the treatment and / or prevention of various human diseases, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; eye disorder; and cancer disorders.o presente pedido de patente refere-se a 2-(5-{1-[2-(difluorometóxi)-6-fluorobenzil]-2-metil-1h-benzimidazol-6-il}pirimidin-2-il)propan-2-ol, ou um sal do mesmo farmaceuticamente aceitável, sendo moduladores potentes da atividade do tnfa humano, são consequentemente de benefício no tratamento e/ou prevenção de várias enfermidades humanas, incluindo distúrbios autoimunes e inflamatórios; distúrbios neurológicos e neurodegenerativos; dor e distúrbios nociceptivos; distúrbios cardiovasculares; distúrbios metabólicos; distúrbio oculares; e distúrbios oncológicos.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充